The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice

Hamed Shafaroodi, Morteza Samini, Leila Moezi, Houman Homayoun, Hamed Sadeghipour, Sina Tavakoli, Amir R. Hajrasouliha, Ahmad Reza Dehpour

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Cannabinoid and opioid receptor agonists show functional interactions in a number of their physiological effects. Regarding the seizure-modulating properties of both classes of receptors, the present study examined the possibility of a functional interaction between these receptors. We used acute systemic administration of cannabinoid selective CB1 receptor agonist (ACPA) and antagonist (AM251) and opioid receptor agonist (morphine) and antagonists (naltrexone and norbinaltorphimine) in a model of clonic seizure induced by pentylenetetrazole (PTZ). Acute administration of ACPA (1.5-2 mg/kg) increased the PTZ-induced seizure threshold. In contrast, AM251 (0.5-2 mg/kg) dose-dependently decreased the seizure threshold. Low dose of AM251 (0.5 mg/kg), which did not alter seizure threshold by itself, reversed the anticonvulsant effect of ACPA (2 mg/kg), showing a CB1 receptor-mediated mechanism. Naltrexone (1 or 10 mg/kg) but not specific κ-opioid receptor antagonist norbinaltorphimine (5 mg/kg) completely reversed the anticonvulsant effect of ACPA (2 mg/kg). Moreover, the combination of the lower doses of AM251 (0.5 mg/kg) and naltrexone (0.3 mg/kg) had an additive effect in blocking the anticonvulsant effect of ACPA. In accordance with previous reports, morphine exerted biphasic effects on clonic seizure threshold with anticonvulsant effect at lower (0.5-1 mg/kg) and proconvulsant effect at a higher (30 mg/kg) doses. The pretreatment with AM251 blocked the anticonvulsant effect of morphine at 1 mg/kg, while pretreatment with ACPA (1 mg/kg) potentiated the anticonvulsant effect of morphine at 0.5 mg/kg. The proconvulsant effect of morphine at 30 mg/kg was also inhibited by AM251 (2 mg/kg). A similar interaction between cannabinoids and opioids was also detected on their anticonvulsant effects against the generalized tonic-clonic model of seizure. In conclusion, cannabinoids and opioids show functional interactions on modulation of seizure susceptibility.

Original languageEnglish (US)
Pages (from-to)390-400
Number of pages11
JournalNeuropharmacology
Volume47
Issue number3
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

Fingerprint

Pentylenetetrazole
Cannabinoids
Opioid Analgesics
Anticonvulsants
Seizures
Morphine
Naltrexone
Cannabinoid Receptor CB1
Narcotic Antagonists
Cannabinoid Receptor Agonists
Opioid Receptors
AM 251

Keywords

  • Cannabinoid
  • Mice
  • Opioid
  • Pentylenetetrazole
  • Seizure threshold

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., ... Dehpour, A. R. (2004). The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology, 47(3), 390-400. https://doi.org/10.1016/j.neuropharm.2004.04.011

The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. / Shafaroodi, Hamed; Samini, Morteza; Moezi, Leila; Homayoun, Houman; Sadeghipour, Hamed; Tavakoli, Sina; Hajrasouliha, Amir R.; Dehpour, Ahmad Reza.

In: Neuropharmacology, Vol. 47, No. 3, 01.09.2004, p. 390-400.

Research output: Contribution to journalArticle

Shafaroodi, H, Samini, M, Moezi, L, Homayoun, H, Sadeghipour, H, Tavakoli, S, Hajrasouliha, AR & Dehpour, AR 2004, 'The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice', Neuropharmacology, vol. 47, no. 3, pp. 390-400. https://doi.org/10.1016/j.neuropharm.2004.04.011
Shafaroodi, Hamed ; Samini, Morteza ; Moezi, Leila ; Homayoun, Houman ; Sadeghipour, Hamed ; Tavakoli, Sina ; Hajrasouliha, Amir R. ; Dehpour, Ahmad Reza. / The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. In: Neuropharmacology. 2004 ; Vol. 47, No. 3. pp. 390-400.
@article{3c18439db79a411c972beb0254261efd,
title = "The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice",
abstract = "Cannabinoid and opioid receptor agonists show functional interactions in a number of their physiological effects. Regarding the seizure-modulating properties of both classes of receptors, the present study examined the possibility of a functional interaction between these receptors. We used acute systemic administration of cannabinoid selective CB1 receptor agonist (ACPA) and antagonist (AM251) and opioid receptor agonist (morphine) and antagonists (naltrexone and norbinaltorphimine) in a model of clonic seizure induced by pentylenetetrazole (PTZ). Acute administration of ACPA (1.5-2 mg/kg) increased the PTZ-induced seizure threshold. In contrast, AM251 (0.5-2 mg/kg) dose-dependently decreased the seizure threshold. Low dose of AM251 (0.5 mg/kg), which did not alter seizure threshold by itself, reversed the anticonvulsant effect of ACPA (2 mg/kg), showing a CB1 receptor-mediated mechanism. Naltrexone (1 or 10 mg/kg) but not specific κ-opioid receptor antagonist norbinaltorphimine (5 mg/kg) completely reversed the anticonvulsant effect of ACPA (2 mg/kg). Moreover, the combination of the lower doses of AM251 (0.5 mg/kg) and naltrexone (0.3 mg/kg) had an additive effect in blocking the anticonvulsant effect of ACPA. In accordance with previous reports, morphine exerted biphasic effects on clonic seizure threshold with anticonvulsant effect at lower (0.5-1 mg/kg) and proconvulsant effect at a higher (30 mg/kg) doses. The pretreatment with AM251 blocked the anticonvulsant effect of morphine at 1 mg/kg, while pretreatment with ACPA (1 mg/kg) potentiated the anticonvulsant effect of morphine at 0.5 mg/kg. The proconvulsant effect of morphine at 30 mg/kg was also inhibited by AM251 (2 mg/kg). A similar interaction between cannabinoids and opioids was also detected on their anticonvulsant effects against the generalized tonic-clonic model of seizure. In conclusion, cannabinoids and opioids show functional interactions on modulation of seizure susceptibility.",
keywords = "Cannabinoid, Mice, Opioid, Pentylenetetrazole, Seizure threshold",
author = "Hamed Shafaroodi and Morteza Samini and Leila Moezi and Houman Homayoun and Hamed Sadeghipour and Sina Tavakoli and Hajrasouliha, {Amir R.} and Dehpour, {Ahmad Reza}",
year = "2004",
month = "9",
day = "1",
doi = "10.1016/j.neuropharm.2004.04.011",
language = "English (US)",
volume = "47",
pages = "390--400",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice

AU - Shafaroodi, Hamed

AU - Samini, Morteza

AU - Moezi, Leila

AU - Homayoun, Houman

AU - Sadeghipour, Hamed

AU - Tavakoli, Sina

AU - Hajrasouliha, Amir R.

AU - Dehpour, Ahmad Reza

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Cannabinoid and opioid receptor agonists show functional interactions in a number of their physiological effects. Regarding the seizure-modulating properties of both classes of receptors, the present study examined the possibility of a functional interaction between these receptors. We used acute systemic administration of cannabinoid selective CB1 receptor agonist (ACPA) and antagonist (AM251) and opioid receptor agonist (morphine) and antagonists (naltrexone and norbinaltorphimine) in a model of clonic seizure induced by pentylenetetrazole (PTZ). Acute administration of ACPA (1.5-2 mg/kg) increased the PTZ-induced seizure threshold. In contrast, AM251 (0.5-2 mg/kg) dose-dependently decreased the seizure threshold. Low dose of AM251 (0.5 mg/kg), which did not alter seizure threshold by itself, reversed the anticonvulsant effect of ACPA (2 mg/kg), showing a CB1 receptor-mediated mechanism. Naltrexone (1 or 10 mg/kg) but not specific κ-opioid receptor antagonist norbinaltorphimine (5 mg/kg) completely reversed the anticonvulsant effect of ACPA (2 mg/kg). Moreover, the combination of the lower doses of AM251 (0.5 mg/kg) and naltrexone (0.3 mg/kg) had an additive effect in blocking the anticonvulsant effect of ACPA. In accordance with previous reports, morphine exerted biphasic effects on clonic seizure threshold with anticonvulsant effect at lower (0.5-1 mg/kg) and proconvulsant effect at a higher (30 mg/kg) doses. The pretreatment with AM251 blocked the anticonvulsant effect of morphine at 1 mg/kg, while pretreatment with ACPA (1 mg/kg) potentiated the anticonvulsant effect of morphine at 0.5 mg/kg. The proconvulsant effect of morphine at 30 mg/kg was also inhibited by AM251 (2 mg/kg). A similar interaction between cannabinoids and opioids was also detected on their anticonvulsant effects against the generalized tonic-clonic model of seizure. In conclusion, cannabinoids and opioids show functional interactions on modulation of seizure susceptibility.

AB - Cannabinoid and opioid receptor agonists show functional interactions in a number of their physiological effects. Regarding the seizure-modulating properties of both classes of receptors, the present study examined the possibility of a functional interaction between these receptors. We used acute systemic administration of cannabinoid selective CB1 receptor agonist (ACPA) and antagonist (AM251) and opioid receptor agonist (morphine) and antagonists (naltrexone and norbinaltorphimine) in a model of clonic seizure induced by pentylenetetrazole (PTZ). Acute administration of ACPA (1.5-2 mg/kg) increased the PTZ-induced seizure threshold. In contrast, AM251 (0.5-2 mg/kg) dose-dependently decreased the seizure threshold. Low dose of AM251 (0.5 mg/kg), which did not alter seizure threshold by itself, reversed the anticonvulsant effect of ACPA (2 mg/kg), showing a CB1 receptor-mediated mechanism. Naltrexone (1 or 10 mg/kg) but not specific κ-opioid receptor antagonist norbinaltorphimine (5 mg/kg) completely reversed the anticonvulsant effect of ACPA (2 mg/kg). Moreover, the combination of the lower doses of AM251 (0.5 mg/kg) and naltrexone (0.3 mg/kg) had an additive effect in blocking the anticonvulsant effect of ACPA. In accordance with previous reports, morphine exerted biphasic effects on clonic seizure threshold with anticonvulsant effect at lower (0.5-1 mg/kg) and proconvulsant effect at a higher (30 mg/kg) doses. The pretreatment with AM251 blocked the anticonvulsant effect of morphine at 1 mg/kg, while pretreatment with ACPA (1 mg/kg) potentiated the anticonvulsant effect of morphine at 0.5 mg/kg. The proconvulsant effect of morphine at 30 mg/kg was also inhibited by AM251 (2 mg/kg). A similar interaction between cannabinoids and opioids was also detected on their anticonvulsant effects against the generalized tonic-clonic model of seizure. In conclusion, cannabinoids and opioids show functional interactions on modulation of seizure susceptibility.

KW - Cannabinoid

KW - Mice

KW - Opioid

KW - Pentylenetetrazole

KW - Seizure threshold

UR - http://www.scopus.com/inward/record.url?scp=3242687074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242687074&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2004.04.011

DO - 10.1016/j.neuropharm.2004.04.011

M3 - Article

C2 - 15275828

AN - SCOPUS:3242687074

VL - 47

SP - 390

EP - 400

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -